Clinical Trials in New York

Showing 461-480 of 22,668 trials

RECRUITINGPhase 2< 1 mile

Cabozantinib for Patients With Recurrent or Progressive Meningioma

NCT05425004

A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

Meningioma

Baptist Health South Florida24 participantsStarted Jun 2022

Miami, Florida, United States • New York, New York, United States • Nashville, Tennessee, United States

TERMINATEDPhase 2< 1 mile

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

NCT05512377

This study is open to adults with advanced cancer in the biliary tract, pancreas, lung, or bladder. This is a study for people for whom previous treatment was not successful or no treatment exists. The purpose of this study is to find out whether a medicine called BI 907828 helps people with cancer in the biliary tract, pancreas, lung, or bladder. BI 907828 is a so-called MDM2 inhibitor that is being developed to treat cancer. All participants take BI 907828 as a tablet once every 3 weeks. Participants may continue to take BI 907828 as long as they benefit from treatment and can tolerate it. They visit the study site regularly. At the study site, doctors regularly check the size of the tumour and whether it has spread to other parts of the body. The doctors also regularly check participants' health and take note of any unwanted effects.

Pancreatic NeoplasmsSolid TumorsBiliary Tract Cancer+2 more

Boehringer Ingelheim99 participantsStarted Dec 2022

Mobile, Alabama, United States • Tucson, Arizona, United States • Los Angeles, California, United States +57 more locations

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Find Trials by Condition in New York

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Horizon Two Adaptive Platform Study in High Risk Newly Diagnosed Multiple Myeloma

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

A Study of BI 3810944 in Patients With Advanced Cancer